Blueprint Medicines Corp

Blueprint Medicines Corp

BPMC

Market Cap$6.55B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Blueprint Medicines CorpBlueprint Medicines Corp-41.4--46%160.4
$150.00

Target Price by Analysts

17.1% upsideBlueprint Medicines Target Price DetailsTarget Price
$95.39

Current Fair Value

25.5% downside

Overvalued by 25.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.55 Billion
Enterprise Value$6.55 Billion
Dividend Yield$0 (0%)
Earnings per Share$-1.07
Beta0.83
Outstanding Shares63,600,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-41.39
PEG41.62
Price to Sales16.01
Price to Book Ratio25.62
Enterprise Value to Revenue11.65
Enterprise Value to EBIT-55.38
Enterprise Value to Net Income-43
Total Debt to Enterprise0.02
Debt to Equity0.37

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Blueprint Medicines Corp

CEO: Jeffrey Albers